# Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus

> **NCT00066716** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 39 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** celecoxib
- **DRUG:** paclitaxel
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00066716
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066716, "Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00066716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*